Bahaa Elgendy, Ph.D.

Associate Professor, Washington University School of Medicine in St. Louis


Dr. Elgendy is an Associate Professor at Washington University School of Medicine in St. Louis. He received his Ph.D. working with Dr. Alan Katritzky at the University of Florida. Following his doctoral studies, Dr. Elgendy pursued postdoctoral research at Scripps Research Institute.

At the Elgendy lab, their primary objective is to develop innovative modulators for undruggable and hard-to-drug targets using cutting-edge medicinal and computational chemistry techniques. Elgendy’s lab has successfully pioneered the development of multiple proprietary classes of small molecules that hold tremendous potential for the treatment of Alzheimer’s and other neurodegenerative diseases, addressing critical medical needs.

Dr. Elgendy is the recipient of several awards, and his lab enjoys funding from esteemed organizations such as the National Institutes of Health (NIH), the Department of Defense (DoD), and the pharmaceutical industry.

To learn more, visit Dr. Elgendy’s profiles at Washington University School of Medicine in St. Louise and LinkedIn  and follow him on social media.

 

Funded Research

These projects were made possible from Cure Alzheimer's Fund support.